Researchers are working to find more effective treatments for children with leukemia.
Through clinical trials, researchers are focused on new AML treatments.
Immunotherapy and monoclonal antibody therapy are both under investigation. Immunotherapy uses substances either from the body or developed in the laboratory to improve the child’s immune system or direct it to more effectively fight cancer cells. In monoclonal antibody therapy, doctors infuse disease-fighting antibodies made in the lab into the child’s body to kill cancer cells or prevent their growth or spread.
Seattle Children’s, a parent organization of Seattle Cancer Care Alliance, actively participates in childhood leukemia research. We take part in the Children’s Oncology Group clinical trials and we are one of the few pediatric centers offering Phase I trials. You can find more information about new treatments that are being researched at the web site of the National Childhood Cancer Foundation.